Trial Profile
Predictive Value of Serum Calprotectin for Treatment Response to Adalimumab or Etanercept in Rheumatoid arthritis Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics; Therapeutic Use
- 04 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism